Full-Time

Associate Scientist

In Vivo Research

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$55k - $65kAnnually

Junior, Mid

Madison, WI, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelor's Degree in Biology or related field and some experience with small animal handling in a research setting (i.e. test article administration and tissue collection) - OR - an Associate Degree in a related area and 7 years of experience.
  • Excellent record-keeping and attention to detail
  • Experience in data analysis, graphing, and making presentations
  • Ability to work independently and to handle multiple projects and deadlines
  • Demonstrated innovation, creativity, and resilience in problem-solving
  • Excellent oral and written communication skills
  • Self-motivated team player with the ability to thrive in a fast-paced, multi-disciplinary, matrixed environment
Responsibilities
  • Perform in vivo studies and ex vivo analysis to facilitate drug discovery and development in various diseases
  • May contribute to the establishment of new preclinical animal disease models
  • Read and apply relevant scientific literature to projects
  • Contribute to the review and drafting of SOPs and other relevant documents
  • Maintain a high level of productivity in the lab and perform critical experiments
  • Prepare and maintain detailed record-keeping of study documents
  • Mentor junior teammates on procedures, processes, and/or other areas as needed
Desired Qualifications
  • Preclinical disease model development in the context of drug discovery
  • Experiences with animal dose administration and surgical procedures
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure that the target genes are significantly reduced in activity. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. Their goal is to provide new options for patients suffering from genetic disorders and to advance the field of gene silencing therapies.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead secured a $500 million facility with Sixth Street for pipeline advancement.
  • Positive Phase 2 data for plozasiran shows promise in treating severe hypertriglyceridemia.
  • Collaboration with Sarepta Therapeutics brings significant financial and research benefits.

What critics are saying

  • Increased competition from companies like Alnylam Pharmaceuticals in the RNAi space.
  • Potential regulatory scrutiny could delay clinical trials for RNAi therapies.
  • Financial instability risk due to reliance on strategic financing agreements.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi to target and silence disease-causing genes effectively.
  • The company has a broad portfolio of RNA chemistries for diverse therapeutic applications.
  • Arrowhead's strategic partnerships enhance its research and development capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave